JNJ Stock Reaches Record Peak at $275.48

Johnson & Johnson (JNJ) reached an all-time high of $275.48 per share on August 19, propelling its market capitalization to a staggering $661 billion.

The healthcare giant's impressive second-quarter performance saw revenue increase by 6.6% year-over-year to reach $25.31 billion, with adjusted earnings per share at $2.90.

These figures exceeded Wall Street projections, prompting leadership to raise their 2026 financial guidance, anticipating approximately $101.1 billion in revenue and adjusted earnings per share of $11.68 (midpoint).

The recent surge benefited from a broader market rotation, with capital flowing toward defensive positions as the Nasdaq experienced downward pressure on Tuesday.